Keratin 37 Inhibitors

Keratin 37 Inhibitors, as a chemical class, encompass a range of compounds that indirectly influence the expression, stability, and function of the protein Keratin 37. These inhibitors are not specific to Keratin 37 but affect cellular pathways and processes that are pivotal for the proper synthesis and maintenance of all proteins, including keratins. Compounds like cycloheximide and emetine exert their effects by impeding protein synthesis at the translational level. These chemicals act on the ribosomal machinery, leading to a decrease in the overall production of proteins, which includes Keratin 37. Other inhibitors, such as MG-132 and chloroquine, target protein degradation pathways. MG-132 specifically inhibits the proteasome, a complex responsible for degrading ubiquitinated proteins, while chloroquine disrupts lysosomal degradation by altering the organelle's pH, both of which can affect the turnover and stability of Keratin 37. Additional compounds, like tunicamycin and brefeldin A, interfere with protein post-translational modifications and trafficking. Tunicamycin impedes N-linked glycosylation, a modification that can be critical for protein folding and stability, while brefeldin A halts protein transport between the endoplasmic reticulum and Golgi apparatus, steps that are essential for protein maturation and sorting. Geldanamycin and its inhibition of Hsp90, a chaperone involved in proper protein folding, represent another strategy by which the function of Keratin 37 could be indirectly affected. The integrity of the cytoskeleton is also crucial for cellular function, and compounds like withaferin A and phalloidin act on cytoskeletal elements, potentially altering their interactions with keratin proteins.